Go to
JCI Insight
Citations to this article
Lindsey N. Kent, … , Alain de Bruin, Gustavo Leone
Published July 25, 2016
Citation Information: J Clin Invest. 2016;126(8):2955-2969. https://doi.org/10.1172/JCI85506.
Citation Information: J Clin Invest. 2016;126(8):2955-2969. https://doi.org/10.1172/JCI85506.
Abstract
E2F-mediated transcriptional repression of cell cycle–dependent gene expression is critical for the control of cellular proliferation, survival, and development. E2F signaling also interacts with transcriptional programs that are downstream of genetic predictors for cancer development, including hepatocellular carcinoma (HCC). Here, we evaluated the function of the atypical repressor genes
Authors
Lindsey N. Kent, Jessica B. Rakijas, Shusil K. Pandit, Bart Westendorp, Hui-Zi Chen, Justin T. Huntington, Xing Tang, Sooin Bae, Arunima Srivastava, Shantibhusan Senapati, Christopher Koivisto, Chelsea K. Martin, Maria C. Cuitino, Miguel Perez, Julian M. Clouse, Veda Chokshi, Neelam Shinde, Raleigh Kladney, Daokun Sun, Antonio Perez-Castro, Ramadhan B. Matondo, Sathidpak Nantasanti, Michal Mokry, Kun Huang, Raghu Machiraju, Soledad Fernandez, Thomas J. Rosol, Vincenzo Coppola, Kamal S. Pohar, James M. Pipas, Carl R. Schmidt, Alain de Bruin, Gustavo Leone
Total citations by year
Citation information
Citations to this article (60)
| Title and authors | Publication | Year |
|---|---|---|
|
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment
Varone E, Retini M, Cherubini A, Chernorudskiy A, Marrazza A, Guidarelli A, Cagnotto A, Beeg M, Gobbi M, Fumagalli S, Bolis M, Guarrera L, Barbera MC, Grasselli C, Bleve A, Generali D, Milani M, Mari M, Salmona M, Piersanti G, Bottegoni G, Broggini M, Janssen-Heininger YM, Cho J, Cantoni O, Zito E |
Cell Death & Disease | 2025 |
|
Early 2-Factor Transcription Factors Associated with Progression and Recurrence in Bevacizumab-Responsive Subtypes of Glioblastoma
Shi J |
Cancers | 2024 |
|
Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice.
Karan D, Dubey S, Gunewardena S, Iczkowski KA, Singh M, Liu P, Poletti A, Choo YM, Chen HZ, Hamann MT |
Molecular Oncology | 2024 |
|
Insight into mammary gland development and tumor progression in an E2F5 conditional knockout mouse model.
To B, Broeker C, Jhan JR, Garcia-Lerena J, Vusich J, Rempel R, Rennhack JP, Hollern D, Jackson L, Judah D, Swiatnicki M, Bylett E, Kubiak R, Honeysett J, Nevins J, Andrechek E |
Oncogene | 2024 |
|
The E2F family: a ray of dawn in cardiomyopathy.
Wei J, Gao C, Lu C, Wang L, Dong D, Sun M |
Molecular and cellular biochemistry | 2024 |
|
Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer
Zheng J, Huang J, Xia J, Zhou W, Dai L, Lin S, Gao L, Zou C |
Frontiers in Oncology | 2023 |
|
Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool
Nakajima R, Zhao L, Zhou Y, Shirasawa M, Uchida A, Murakawa H, Fikriyanti M, Iwanaga R, Bradford AP, Araki K, Warita T, Ohtani K |
Genes & development | 2023 |
|
Risk modeling of single-cell transcriptomes reveals the heterogeneity of immune infiltration in hepatocellular carcinoma
Wang L, Chen Y, Chen R, Mao F, Sun Z, Liu X |
The Journal of biological chemistry | 2023 |
|
Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers.
Venkadakrishnan VB, Yamada Y, Weng K, Idahor O, Beltran H |
Molecular cancer research : MCR | 2023 |
|
Cellular polyploidy in organ homeostasis and regeneration.
Fang J, de Bruin A, Villunger A, Schiffelers R, Lei Z, Sluijter JPG |
Protein & Cell | 2023 |
|
A Nucleotide Metabolism-Related Gene Signature for Risk Stratification and Prognosis Prediction in Hepatocellular Carcinoma Based on an Integrated Transcriptomics and Metabolomics Approach
Wei T, Liu J, Ma S, Wang M, Yuan Q, Huang A, Wu Z, Shang D, Yin P |
Metabolites | 2023 |
|
Multi-dimension metabolic prognostic model for gastric cancer
Feng W, Xu B, Zhu X |
Frontiers in Endocrinology | 2023 |
|
The Ploidy State as a Determinant of Hepatocyte Proliferation
Wilson SR, Duncan AW |
Seminars in liver disease | 2023 |
|
OSgc: A Web Portal to Assess the Performance of Prognostic Biomarkers in Gastric Cancer
L Xie, Q Wang, Z Yan, Y Han, X Ma, H Li, L Zhang, X Li, X Guo |
Frontiers in Oncology | 2022 |
|
Gene repression through epigenetic modulation by PPARA enhances hepatocellular proliferation
D Aibara, S Takahashi, T Yagai, D Kim, C Brocker, M Levi, K Matsusue, F Gonzalez |
iScience | 2022 |
|
Enhancer methylation dynamics drive core transcriptional regulatory circuitry in pan-cancer
X Pan, X Li, J Sun, Z Xiong, H Hu, S Ning, H Zhi |
Oncogene | 2022 |
|
Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma
Kumar D, Das M, Oberg A, Sahoo D, Wu P, Sauceda C, Jih L, Ellies LG, Langiewicz MT, Sen S, Webster NJ |
Advanced Science | 2022 |
|
Raising of Anillin expression in para-cancerous hepatocytes is associated with hepatic depolyploidization and short-term recurrence of hepatocellular carcinoma after radical operation
Wang N, Hao F, Zhang Y, Xu W, Chen Y, Fei X, Wang J |
Journal of Cancer | 2022 |
|
Wnt signaling regulates hepatocyte cell division by a transcriptional repressor cascade.
Jin Y, Anbarchian T, Wu P, Sarkar A, Fish M, Peng WC, Nusse R |
Proceedings of the National Academy of Sciences | 2022 |
|
Centriole signaling restricts hepatocyte ploidy to maintain liver integrity.
Sladky VC, Akbari H, Tapias-Gomez D, Evans LT, Drown CG, Strong MA, LoMastro GM, Larman T, Holland AJ |
Genes & development | 2022 |
|
Comprehensive bioinformatics analysis of the E2F family in human clear cell renal cell carcinoma
Liu ZG, Su J, Liu H, Yang XJ, Yang X, Wei Y, Zhu XY, Song Y, Zhao XC, Guo HL |
Oncology Letters | 2022 |
|
Inhibition of polyploidization in Pten‐deficient livers reduces steatosis
Moreno E, Matondo AB, Bongiovanni L, van de Lest CH, Molenaar MR, Toussaint MJ, van Essen SC, Houweling M, Helms JB, Westendorp B, de Bruin A |
Liver International | 2022 |
|
E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice
E Moreno, MJ Toussaint, SC Essen, L Bongiovanni, EA Liere, MH Koster, R Yuan, JM Deursen, B Westendorp, A Bruin |
Hepatology | 2021 |
|
Hepatocyte Polyploidy: Driver or Gatekeeper of Chronic Liver Diseases
R Donne, F Sangouard, S Celton-Morizur, C Desdouets |
Cancers | 2021 |
|
Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma
M Fischietti, F Eckerdt, GT Blyth, AD Arslan, WM Mati, CV Oku, RE Perez, C Lee-Chang, EM Kosciuczuk, D Saleiro, EM Beauchamp, MS Lesniak, D Verzella, L Sun, EN Fish, GY Yang, W Qiang, LC Platanias |
Oncogene | 2021 |
|
Ploidy dynamics increase the risk of liver cancer initiation
M Müller, S May, TG Bird |
Nature Communications | 2021 |
|
Methyl Ferulic Acid Attenuates Human Cardiac Fibroblasts Differentiation and Myocardial Fibrosis by Suppressing pRB-E2F1/CCNE2 and RhoA/ROCK2 Pathway
R Liao, Z Qi, R Tang, R Wang, Y Wang |
Frontiers in pharmacology | 2021 |
|
H2AFZ: A Novel Prognostic Marker in Canine Melanoma and a Predictive Marker for Resistance to CDK4/6 Inhibitor Treatment
L Bongiovanni, A Andriessen, S Silvestri, I Porcellato, C Brachelente, A de Bruin |
Frontiers in Veterinary Science | 2021 |
|
E2F transcription factor 1 (E2F1) promotes the transforming growth factor TGF-β1 induced human cardiac fibroblasts differentiation through promoting the transcription of CCNE2 gene
R Liao, B Xie, J Cui, Z Qi, S Xue, Y Wang |
Bioengineered | 2021 |
|
Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma
H Luo, C Tao, X Long, X Zhu, K Huang |
Bioengineered | 2021 |
|
Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
W Xu, X Lu, J Liu, Q Chen, X Huang, K Huang, H Liu, W Zhu, X Zhang |
Frontiers in Oncology | 2021 |
|
Bifidobacterium Strain-Specific Enhances the Efficacy of Cancer Therapeutics in Tumor-Bearing Mice
Y Yoon, G Kim, BN Jeon, S Fang, H Park |
Cancers | 2021 |
|
Atypical E2Fs either Counteract or Cooperate with RB during Tumorigenesis Depending on Tissue Context
E Moreno, SK Pandit, MJ Toussaint, L Bongiovanni, L Harkema, SC van Essen, EA van Liere, B Westendorp, A de Bruin |
Cancers | 2021 |
|
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles
Andriessen A, Bongiovanni L, Driedonks TA, van Liere E, Seijger A, Hegeman CV, van Nimwegen SA, Galac S, Westendorp B, Nolte\u2010't Hoen EN, de Bruin A |
Veterinary and Comparative Oncology | 2021 |
|
Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury
PD Wilkinson, AW Duncan |
Seminars in liver disease | 2020 |
|
Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia
DG Cucchi, C Bachas, MM van den Heuvel-Eibrink, ST Arentsen-Peters, ZJ Kwidama, GJ Schuurhuis, YG Assaraf, V de Haas, GJ Kaspers, J Cloos |
Cancers | 2020 |
|
PIDDosome‐induced p53‐dependent ploidy restriction facilitates hepatocarcinogenesis
VC Sladky, K Knapp, TG Szabo, VZ Braun, L Bongiovanni, H Bos, DC Spierings, B Westendorp, A Curinha, T Stojakovic, H Scharnagl, G Timelthaler, K Tsuchia, M Pinter, G Semmler, F Foijer, A Bruin, T Reiberger, N RohrUdilova, A Villunger |
EMBO reports | 2020 |
|
Integrated analysis of the E2F transcription factors across cancer types
H Wang, X Wang, L Xu, J Zhang, H Cao |
Oncology reports | 2020 |
|
Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report
Y Lü, J Zhang, L Li, S Li, Z Yang |
Bioscience Reports | 2020 |
|
Hepatocyte ploidy modulation in liver cancer
AW Duncan |
EMBO reports | 2020 |
|
Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data
Z Liu, W Zhou, C Lin, X Wang, X Zhang, Y Zhang, R Yang, W Chen, W Cao |
Aging | 2020 |
|
NT5DC2 is a novel prognostic marker in human hepatocellular carcinoma
J Chen, J Cao, P Wang, X He |
Oncology Letters | 2020 |
|
Polyploid Hepatocytes Facilitate Adaptation and Regeneration to Chronic Liver Injury
PD Wilkinson, F Alencastro, ER Delgado, MP Leek, MP Weirich, PA Otero, N Roy, WK Brown, M Oertel, AW Duncan |
The American Journal of Pathology | 2019 |
|
The Polyploid State Restricts Hepatocyte Proliferation and Liver Regeneration in Mice: Hepatology
PD Wilkinson, ER Delgado, F Alencastro, MP Leek, N Roy, MP Weirich, EC Stahl, PA Otero, MI Chen, WK Brown, AW Duncan |
Hepatology | 2019 |
|
Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma YL Huang, G Ning, LB Chen, YF Lian, YR Gu, JL Wang, DM Chen, H Wei, YH Huang |
Cancer management and research | 2019 |
|
Two Distinct E2F Transcriptional Modules Drive Cell Cycles and Differentiation
MC Cuitiño, T Pécot, D Sun, R Kladney, T Okano-Uchida, N Shinde, R Saeed, AJ Perez-Castro, A Webb, T Liu, SI Bae, L Clijsters, N Selner, V Coppola, C Timmers, MC Ostrowski, M Pagano, G Leone |
Cell Reports | 2019 |
|
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase
VR Sanghvi, J Leibold, M Mina, P Mohan, M Berishaj, Z Li, MM Miele, N Lailler, C Zhao, E de Stanchina, A Viale, L Akkari, SW Lowe, G Ciriello, RC Hendrickson, HG Wendel |
Cell | 2019 |
|
CDK2 regulates the NRF1/ Ehmt1 axis during meiotic prophase I
N Palmer, SZ Talib, CK Ratnacaram, D Low, X Bisteau, JH Lee, E Pfeiffenberger, H Wollmann, JH Tan, S Wee, R Sobota, J Gunaratne, DM Messerschmidt, E Guccione, P Kaldis |
The Journal of Cell Biology | 2019 |
|
Cyclin F‐dependent degradation of E2F7 is critical for DNA repair and G2‐phase progression
R Yuan, Q Liu, HA Segeren, L Yuniati, D Guardavaccaro, RJ Lebbink, B Westendorp, A de Bruin |
The EMBO Journal | 2019 |
|
The broken cycle: E2F dysfunction in cancer
L Kent, G Leone |
Nature Reviews Cancer | 2019 |
|
Atypical E2f functions are critical for pancreas polyploidization
RB Matondo, E Moreno, MJ Toussaint, PC Tooten, SC van Essen, EA van Liere, SA Youssef, L Bongiovanni, A de Bruin, FX Real |
PloS one | 2018 |
|
The Polyploid State Plays a Tumor-Suppressive Role in the Liver
S Zhang, K Zhou, X Luo, L Li, HC Tu, A Sehgal, LH Nguyen, Y Zhang, P Gopal, BD Tarlow, DJ Siegwart, H Zhu |
Developmental Cell | 2018 |
|
Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest
R Yuan, HR Vos, RM van Es, J Chen, BM Burgering, B Westendorp, A de Bruin |
The EMBO Journal | 2018 |
|
MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis
YS Ma, ZW Lv, F Yu, ZY Chang, XL Cong, XM Zhong, GX Lu, J Zhu, D Fu |
Journal of Experimental & Clinical Cancer Research | 2018 |
|
Dosage-dependent copy number gains in E2f1 and E2f3 drive HCC
Lindsey Kent, SooIn Bae, Shih-Yin Tsai, Xing Tang, Arunima Srivastava, Christopher Koivisto, Chelsea Martin, Elisa Ridolfi, Grace Miller, Sarah Zorko, Emilia Plevris, Yannis Hadjiyannis, Miguel Perez, Eric Nolan, Raleigh Kladney, Bart Westendorp, Alain De Bruin, Soledad Fernandez, Thomas Rosol, Kamal Pohar, James Pipas, Gustavo Leone |
Journal of Clinical Investigation | 2017 |
|
E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma
Y Lv, J Xiao, J Liu, F Xing |
Journal of Cancer | 2017 |
|
Dietary fat/cholesterol-sensitive PKCβ-RB signaling: Potential role in NASH/HCC axis
W Huang, D Mehta, S Sif, LN Kent, ST Jacob, K Ghoshal, KD Mehta |
Oncotarget | 2017 |
|
Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells
DH Jin, Y Kim, BB Lee, J Han, HK Kim, YM Shim, DH Kim |
Oncotarget | 2017 |
|
Atypical E2Fs inhibit tumor angiogenesis
BG Weijts, B Westendorp, BT Hien, LM Martínez-López, M Zijp, I Thurlings, RE Thomas, S Schulte-Merker, WJ Bakker, A de Bruin |
Oncogene | 2017 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)